These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 10890476

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Is an increase in lactate concentration associated with cardiac dysfunction after the Fontan procedure?
    Hamamoto M, Imanaka H, Kagisaki K, Yagihara T, Kitamura S, Nishimura M.
    Ann Thorac Cardiovasc Surg; 2005 Oct; 11(5):301-6. PubMed ID: 16299456
    [Abstract] [Full Text] [Related]

  • 44. Optimal timing of the Fontan conversion: change in the P-wave characteristics precedes the onset of atrial tachyarrhythmias in patients with atriopulmonary connection.
    Koh M, Yagihara T, Uemura H, Kagisaki K, Hagino I, Ishizaka T, Kitamura S.
    J Thorac Cardiovasc Surg; 2007 May; 133(5):1295-302. PubMed ID: 17467444
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Protocols associated with no mortality in 100 consecutive Fontan procedures.
    Jacobs ML, Pelletier GJ, Pourmoghadam KK, Mesia CI, Madan N, Stern H, Schwartz R, Murphy JD.
    Eur J Cardiothorac Surg; 2008 Apr; 33(4):626-32. PubMed ID: 18243008
    [Abstract] [Full Text] [Related]

  • 51. The modified Fontan procedure and prolonged pleural effusions.
    Mascio CE, Wayment M, Colaizy TT, Mahoney LT, Burkhart HM.
    Am Surg; 2009 Feb; 75(2):175-7. PubMed ID: 19280814
    [Abstract] [Full Text] [Related]

  • 52. The extracardiac conduit Fontan operation using minimal approach extracorporeal circulation: early and midterm outcomes.
    Petrossian E, Reddy VM, Collins KK, Culbertson CB, MacDonald MJ, Lamberti JJ, Reinhartz O, Mainwaring RD, Francis PD, Malhotra SP, Gremmels DB, Suleman S, Hanley FL.
    J Thorac Cardiovasc Surg; 2006 Nov; 132(5):1054-63. PubMed ID: 17059923
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. [Failed transcatheter creation of fenestration in a Fontan patient with original fenestration closed by AngelWings septal occluder: a case report].
    Ohno A, Hirotaka I, Kobayashi T, Asano H, Kyo S, Senzaki H.
    J Cardiol; 2007 Oct; 50(4):271-5. PubMed ID: 17987844
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Which may be effective to reduce blood loss after cardiac operations in cyanotic children: tranexamic acid, aprotinin or a combination?
    Bulutcu FS, Ozbek U, Polat B, Yalçin Y, Karaci AR, Bayindir O.
    Paediatr Anaesth; 2005 Jan; 15(1):41-6. PubMed ID: 15649162
    [Abstract] [Full Text] [Related]

  • 57. Antifibrinolytics.
    Schmarts.
    Acta Anaesthesiol Belg; 2003 Jan; 54(4):319-22. PubMed ID: 14719353
    [No Abstract] [Full Text] [Related]

  • 58. Aprotinin use in cardiac surgery patients at low risk for requiring blood transfusion.
    Kristeller JL, Stahl RF, Roslund BP, Roke-Thomas M.
    Pharmacotherapy; 2007 Jul; 27(7):988-94. PubMed ID: 17594204
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Tranexamic acid and aprotinin in low- and intermediate-risk cardiac surgery: a non-sponsored, double-blind, randomised, placebo-controlled trial.
    Later AF, Maas JJ, Engbers FH, Versteegh MI, Bruggemans EF, Dion RA, Klautz RJ.
    Eur J Cardiothorac Surg; 2009 Aug; 36(2):322-9. PubMed ID: 19250838
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.